Skip to main content
Poly Medicure Ltd logo

Poly Medicure Ltd — Investor Relations & Filings

Ticker · POLYMED ISIN · INE205C01021 LEI · 335800XM9YRKFWFVXO61 BSE.NS Manufacturing
Filings indexed 1,065 across all filing types
Latest filing 2021-02-18 Regulatory Filings
Country IN India
Listing BSE.NS POLYMED

About Poly Medicure Ltd

https://www.polymedicure.com

Poly Medicure Ltd, known as Polymed, is a global medical device company specializing in the design, development, and manufacture of high-quality medical consumables and equipment. The company offers a comprehensive portfolio of over 160 products across various clinical segments, including infusion therapy, oncology, anesthesia, urology, gastroenterology, blood management, and dialysis. Key offerings include IV cannulas, central venous catheters, blood collection systems, and respiratory care devices. With a strong emphasis on research and development, the company operates multiple state-of-the-art manufacturing facilities and maintains international quality certifications. Polymed serves a diverse global market, providing cost-effective and innovative healthcare solutions to hospitals and medical professionals worldwide.

Recent filings

Filing Released Lang Actions
We wish to inform you that in respect of the QIP, the QIP Committee of the Company has, at its meeting held today approved and adopted the placement document dated February 18, 2021 in ....
Regulatory Filings
2021-02-18 English
Further to our letter dated February 15, 2021 intimating you about the meeting of the QIP Committee in respect of the Issue to be held on February 18, 2021. We wish to inform you that the ....
Regulatory Filings
2021-02-18 English
Updates
Regulatory Filings Classification · 95% confidence The document text is extremely short (754 characters) and contains only header information related to stock exchanges and scrip codes, with no substantive content or financial data. There is no indication of a full report, financial statements, or detailed disclosures. It appears to be a brief announcement or notice, possibly related to regulatory or exchange communication. Given the brevity and lack of detailed content, this fits the pattern of a Regulatory Filing (RNS), which is a fallback category for miscellaneous filings that do not fit other specific categories.
2021-02-18 English
Dear Sir, Further to our letter dated February 15, 2021 intimating you about the meeting of the QIP Committee in respect of the Issue to be held on February 18, 2021. We wish to ....
Regulatory Filings
2021-02-18 English
Updates
Regulatory Filings Classification · 90% confidence The document text is extremely short (117 characters) and contains no substantive content, only placeholders for images. There is no financial data, no report title, no regulatory references, or any indication of the document's purpose. Given the lack of content, it cannot be classified as a report or announcement of a report. According to the rules, such minimal content defaults to Regulatory Filings (RNS) as a fallback category.
2021-02-18 English
We wish to inform you that pursuant to the approval accorded by the board of directors of the Company (the 'Board'), at its meeting held on December 8, 2020 and special resolution passed ....
Regulatory Filings
2021-02-15 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.